X-linked agammaglobulinemia (XLA) is an immune disorder that causes extremely low levels of B cells, which are an important part of the immune system. XLA can put a person at risk of frequent ...
Please provide your email address to receive an email when new articles are posted on . ATSN-201 is being evaluated for the treatment of X-linked retinoschisis. The gene therapy previously received ...
Please provide your email address to receive an email when new articles are posted on . Atsena Therapeutics completed patient dosing in part A of the phase 1/2 LIGHTHOUSE clinical trial investigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results